FGF23 and hyperparathyroidism: Initial clinical assessments revealed biochemical and hormonal imbalances, characterized by hypophosphatemia, hyperparathyroidism, vitamin D deficiency, hyperalkaline phosphatasemia, and elevated levels of FGF23 and its co‐receptor α‐Klotho, while serum calcium levels remained within normal parameters (Table S1, Supporting Information).